We are live on ! Find out more
VP

Vitruvian Partners Portfolio holdings

AUM $201M Turnover 12.5%
1-Year Est. Return 10.44%
This Fund
S&P 500
This Quarter Est. Return
+37.96%
1 Year Est. Return
+10.44%
3 Year Est. Return
+64.35%
5 Year Est. Return
-5.3%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$89.1M
Cap. Flow
-$41.8M
Cap. Flow %
-20.78%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
3
Closed
–
Avg Time Held
2.7 years
Top 10 Avg Time Held
2.7 years
Top 20 Avg Time Held
2.7 years

Top Buys

Rank Stock Value
1
WSE icon
Wise Group
WSE
+$3.36M

Top Sells

Rank Stock Value
1
HNGE icon
Hinge Health
HNGE
+$40.4M
2
CARG icon
CarGurus
CARG
+$3.98M
3
XMTR icon
Xometry
XMTR
+$768K

Sector Composition

Rank Sector Weight
1 Technology 57.05%
2 Healthcare 24.68%
3 Industrials 8.7%
4 Communication Services 5.94%
5 Consumer Discretionary 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MQ icon
1
Marqeta
MQ
$1.95B
$111M 55.38%
1,713,296
– –
2021 Q2
20 quarters
HNGE icon
2
Hinge Health
HNGE
$8.68B
$42M 20.92%
506,599
-743,401
-59% -$40.4M
2025 Q2
4 quarters
XMTR icon
3
Xometry
XMTR
$5.37B
$17.5M 8.7%
181,169
-10,750
-6% -$768K
2023 Q2
12 quarters
CARG icon
4
CarGurus
CARG
$2.82B
$11.9M 5.94%
350,044
-122,915
-26% -$3.98M
2021 Q1
21 quarters
GLBE icon
5
Global E Online
GLBE
$7.02B
$7.3M 3.63%
210,209
– –
2025 Q1
5 quarters
MXCT icon
6
MaxCyte
MXCT
$148M
$6.2M 3.09%
5,043,356
– –
2021 Q3
19 quarters
WSE icon
7
Wise Group
WSE
$10.7B
$3.35M 1.67%
+281,277
New +$3.36M
2026 Q2
0 quarters
RXST icon
8
RxSight
RXST
$203M
$1.34M 0.67%
278,865
– –
2024 Q4
6 quarters

Similar funds

Vitruvian Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Vitruvian Partners held 8 positions worth $201M, up 80% from $112M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vitruvian Partners withdrew a net $41.8M in Q2 2026, reducing 3 holdings. Its largest reduction was Hinge Health, cutting an estimated $40.4M.

By sector, the portfolio is most concentrated in Technology at 57% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vitruvian Partners opened a new position in Wise Group worth $3.35M.

  • Vitruvian Partners's largest Q2 2026 buy was Wise Group: 281,277 shares worth $3.35M.
  • Vitruvian Partners's biggest Q2 2026 reduction was Hinge Health, cutting an estimated $40.4M.
  • Vitruvian Partners's ten largest holdings make up 100% of its $201M portfolio in Q2 2026.
  • Vitruvian Partners opened 1 new position and closed 0 in Q2 2026.
  • Vitruvian Partners's portfolio value rose 80% quarter-over-quarter to $201M.

Based on Vitruvian Partners's 13F filing for Q2 2026, filed 10 Aug 2026.